BIOBIJOU Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	28,491	29,633	17,130
Revenue Growth (YoY)	-3.85%	72.99%	-
Cost of Revenue	12,612	14,815	8,871
Gross Profit	15,879	14,819	8,259
Selling, General & Admin	10,080	3,982	2,311
Research & Development	841.97	1,213	632.7
Amortization of Goodwill & Intangibles	28.6	13.84	6.53
Other Operating Expenses	64.02	47.52	29.74
Operating Expenses	11,651	5,592	3,094
Operating Income	4,227	9,227	5,165
Interest Expense	-38.2	-444.24	-594.63
Interest & Investment Income	421.23	205.4	126.48
Currency Exchange Gain (Loss)	120.88	765.23	400.31
Other Non Operating Income (Expenses)	14.87	-922.33	-949.25
EBT Excluding Unusual Items	4,746	8,831	4,148
Gain (Loss) on Sale of Investments	249.1	148.3	79.14
Gain (Loss) on Sale of Assets	3.64	-	0.65
Pretax Income	4,999	8,979	4,227
Income Tax Expense	846.93	1,791	917.41
Earnings From Continuing Operations	4,152	7,188	3,310
Minority Interest in Earnings	0.02	-	-
Net Income	4,152	7,188	3,310
Net Income to Common	4,152	7,188	3,310
Net Income Growth	-42.24%	117.16%	-
Shares Outstanding (Basic)	14	11	11
Shares Outstanding (Diluted)	14	11	11
Shares Change (YoY)	22.11%	6.21%	-
EPS (Basic)	298.00	630.00	308.13
EPS (Diluted)	298.00	630.00	308.13
EPS Growth	-52.70%	104.46%	-
Free Cash Flow	-3,120	461.05	4,038
Free Cash Flow Per Share	-223.92	40.41	375.87
Gross Margin	55.73%	50.01%	48.21%
Operating Margin	14.84%	31.14%	30.15%
Profit Margin	14.57%	24.26%	19.32%
Free Cash Flow Margin	-10.95%	1.56%	23.57%
EBITDA	5,002	9,927	5,752
EBITDA Margin	17.56%	33.50%	33.58%
D&A For EBITDA	774.43	700.16	587.04
EBIT	4,227	9,227	5,165
EBIT Margin	14.84%	31.14%	30.15%
Effective Tax Rate	16.94%	19.95%	21.70%
Advertising Expenses	3,845	469.22	188.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.